ADA Scientific Sessions 2026 Abstract

Efficacy and Safety of Simplified SGLT2i-Based Stepwise Intensive Therapy in Inducing of Diabetes Remission in Newly Diagnosed Type 2 Diabetes with Severe Hyperglycemia: A Pilot Study

By Liehua Liu, Weijian Ke, Songwen Tang, Yanbing Li

Trial in peopleInterventions

The paper

Liehua Liu, Weijian Ke, Songwen Tang, Yanbing Li

Guangzhou

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, poster 1845-P

doi.org/10.2337/db26-1845-p

Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes